felodipine has been researched along with Kidney Failure, Chronic in 10 studies
Felodipine: A dihydropyridine calcium antagonist with positive inotropic effects. It lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels.
felodipine : The mixed (methyl, ethyl) diester of 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid. A calcium-channel blocker, it lowers blood pressure by reducing peripheral vascular resistance through a highly selective action on smooth muscle in arteriolar resistance vessels. It is used in the management of hypertension and angina pectoris.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Out of 139 patients who received cadaveric kidney transplants between March 1990 and December 1991 22 were treated with the CCB agent felodipine as antihypertensive therapy on admission and post transplant." | 3.69 | Early renal graft function in recipients treated with the calcium channel blocker felodipine. ( Blohmé, I; Haljamäe, U; Herlitz, H; Nordén, G; Nyberg, G, 1994) |
| "Felodipine is a dihydropyridine calcium antagonist which lowers total peripheral resistance and blood pressure in doses which have no effect on cardiac conduction and contractility." | 2.38 | Renal effects of felodipine--a review. ( Edgar, B; Elmfeldt, D; Nordlander, M, 1992) |
| "Enalapril treatment (5 mg/kg/day, n = 11) or felodipine (30 mg/kg/day, n = 11) reduced systolic blood pressure to a comparable degree." | 1.27 | Disparate effects of angiotensin converting enzyme inhibitor and calcium blocker treatment on the preservation of renal structure and function following subtotal nephrectomy or streptozotocin-induced diabetes in the rat. ( Cubela, R; Debrevi, L; Jackson, B; Johnston, CI; Whitty, M, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (30.00) | 18.7374 |
| 1990's | 6 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khan, YH | 1 |
| Sarriff, A | 1 |
| Adnan, AS | 1 |
| Khan, AH | 1 |
| Malhi, TH | 1 |
| Jummaat, F | 1 |
| Nyberg, G | 2 |
| Haljamäe, U | 1 |
| Herlitz, H | 3 |
| Nordén, G | 1 |
| Blohmé, I | 1 |
| Pan, Y | 1 |
| Grindstaff, A | 1 |
| Cassada, D | 1 |
| Goldman, M | 1 |
| Taylor, J | 1 |
| Ni, Z | 1 |
| Wang, XQ | 1 |
| Vaziri, ND | 1 |
| Nordlander, M | 2 |
| Havu, N | 1 |
| Elmfeldt, D | 1 |
| Edgar, B | 1 |
| Jackson, B | 2 |
| Cubela, R | 1 |
| Debrevi, L | 1 |
| Whitty, M | 1 |
| Johnston, CI | 2 |
| Granérus, G | 1 |
| Björck, S | 1 |
| Aurell, M | 1 |
1 review available for felodipine and Kidney Failure, Chronic
| Article | Year |
|---|---|
Renal effects of felodipine--a review.
Topics: Animals; Diuresis; Felodipine; Glomerular Filtration Rate; Humans; Ischemia; Kidney; Kidney Failure, | 1992 |
9 other studies available for felodipine and Kidney Failure, Chronic
| Article | Year |
|---|---|
Complications associated with End Stage Renal Disease.
Topics: Ceftazidime; Diabetes Mellitus, Type 2; Diabetic Foot; Diabetic Nephropathies; Diabetic Neuropathies | 2015 |
Early renal graft function in recipients treated with the calcium channel blocker felodipine.
Topics: Adolescent; Adult; Aged; Blood Flow Velocity; Cadaver; Creatinine; Cyclosporine; Felodipine; Female; | 1994 |
Bilateral reduction mammoplasty in a patient treated with calcium channel blocker and cyclosporine after renal transplant: a case report.
Topics: Adult; Breast Diseases; Cadaver; Calcium Channel Blockers; Cyclosporine; Felodipine; Female; Humans; | 1997 |
Nitric oxide metabolism in erythropoietin-induced hypertension: effect of calcium channel blockade.
Topics: Animals; Blood Pressure; Blotting, Western; Calcium; Calcium Channel Blockers; Drug Interactions; Er | 1998 |
Effects of chronic felodipine treatment on renal function and morphology in SHR.
Topics: Animals; Blood Pressure; Creatinine; Drug Synergism; Felodipine; Female; Glomerulosclerosis, Focal S | 1992 |
Long-term effects of felodipine in patients with reduced renal function.
Topics: Adult; Aged; Blood Pressure; Felodipine; Female; Glomerular Filtration Rate; Humans; Hypertension, R | 1992 |
Disparate effects of angiotensin converting enzyme inhibitor and calcium blocker treatment on the preservation of renal structure and function following subtotal nephrectomy or streptozotocin-induced diabetes in the rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium Channel Blockers; Diabetes Mellitus, Expe | 1987 |
The contribution of systemic hypertension to progression of chronic renal failure in the rat remnant kidney: effect of treatment with an angiotensin converting enzyme inhibitor or a calcium inhibitor.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Calcium Channel Blockers; Enalapr | 1988 |
Effects of felodipine in patients with refractory hypertension and progressive renal disease.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Drug Ther | 1988 |